Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington’s disease by etanercept treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington’s disease by etanercept treatment ; volume:9 ; number:1 ; day:10 ; month:5 ; year:2019 ; pages:1-12 ; date:12.2019
Scientific reports ; 9, Heft 1 (10.5.2019), 1-12, 12.2019
- Urheber
-
Pido-Lopez, Jeffrey
Tanudjojo, Benedict
Farag, Sahar
Bondulich, Marie-Katrin
Andre, Ralph
Tabrizi, Sarah J.
Bates, Gillian (Molekulargenetiker)
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-43627-3
- URN
-
urn:nbn:de:101:1-2019072220351841769784
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pido-Lopez, Jeffrey
- Tanudjojo, Benedict
- Farag, Sahar
- Bondulich, Marie-Katrin
- Andre, Ralph
- Tabrizi, Sarah J.
- Bates, Gillian (Molekulargenetiker)
- SpringerLink (Online service)
Ähnliche Objekte (12)
A novel form of necrosis, TRIAD, occurs in human Huntington’s disease
Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington’s Disease
Huntington
Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
Aripiprazol im R6/2-Mausmodell als Therapieansatz bei Chorea Huntington
Huntington's chorea
Chorea Huntington
Huntington-Erkrankung
Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice
Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
Targeting Huntington’s disease through histone deacetylases
Cardiac autonomic involvement in Huntington’s disease
A novel form of necrosis, TRIAD, occurs in human Huntington’s disease
Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington’s Disease
Huntington
Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
Aripiprazol im R6/2-Mausmodell als Therapieansatz bei Chorea Huntington
Huntington's chorea
Chorea Huntington
Huntington-Erkrankung
Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice
Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
Targeting Huntington’s disease through histone deacetylases
Cardiac autonomic involvement in Huntington’s disease
A novel form of necrosis, TRIAD, occurs in human Huntington’s disease
Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington’s Disease
Huntington
Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
Aripiprazol im R6/2-Mausmodell als Therapieansatz bei Chorea Huntington
Huntington's chorea
Chorea Huntington
Huntington-Erkrankung
Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice
Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
Targeting Huntington’s disease through histone deacetylases